Performance analysis of CAMP4 Therapeutics (CAMP)
Annual Return
Since Oct 11, 2024, CAMP has had an average annual return of -43.69%, underperforming the benchmark SPY, which returned +18.64% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.97% | +17.44% | -51.31% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -39.65% | +21.36% | -1.77% | -5.44% | +5.27% | -5.01% | -31.97% | ||||||
| 2025 | -7.85% | +2.07% | -18.54% | -55.75% | +11.87% | -26.75% | +12.42% | -6.77% | +97.39% | +38.66% | -8.66% | +61.30% | +17.44% |
| 2024 | -0.84% | -54.94% | +8.97% | -51.31% |
Drawdown analysis of CAMP4 Therapeutics (CAMP)
The maximum drawdown for the CAMP was -88.50%, occurring on Jul 1, 2025. This drawdown has not yet recovered.
The current CAMP drawdown is -64.48%.
Since Oct 11, 2024 CAMP has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -88.50% | Nov 12, 2024 | 156 | Jul 1, 2025 | Ongoing | Ongoing | Ongoing |
| -27.70% | Oct 29, 2024 | 4 | Nov 4, 2024 | 6 | Nov 12, 2024 | 10 |
| -9.05% | Oct 11, 2024 | 1 | Oct 14, 2024 | 1 | Oct 15, 2024 | 2 |
| -0.91% | Oct 18, 2024 | 1 | Oct 21, 2024 | 4 | Oct 25, 2024 | 5 |
| -0.71% | Oct 25, 2024 | 1 | Oct 28, 2024 | 1 | Oct 29, 2024 | 2 |
| -0.55% | Oct 16, 2024 | 1 | Oct 17, 2024 | 1 | Oct 18, 2024 | 2 |